Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [clinicaltrials:NCT00158457]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660
Bio2RDF identifier
8cda0e6f287e61e6525bb53c07423660
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660
measure [clinicaltrials_vocabulary:measure]
Evaluation of the antiretrovir ...... tion to treat (ITT) population
time frame [clinicaltrials_vocabulary:time-frame]
identifier
clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660
title
Evaluation of the antiretrovir ...... to treat (ITT) population S48
@en
inDataset
type
label
Evaluation of the antiretrovir ...... a0e6f287e61e6525bb53c07423660]
@en